NCT01699997View on ClinicalTrials.gov

Oxytocin as Adjunctive Therapy for Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

April 30, 2015

Study Completion Date

November 30, 2015

Conditions
Schizophrenia
Interventions
DRUG

Oxytocin

Intranasal spray with 40 IU of OXT

DRUG

Placebo

Intranasal spray with placebo solution

Trial Locations (7)

20129

Institute of Neuroscience, National Research Council, Milan

25024

Department of Mental Health, Desenzano

25125

IRCCS Fatebenefratelli, Brescia

33100

Psychiatric Clinic, University of Udine, Udine

35124

Department of Mental Health, Padua

56100

Psychiatric Clinic, University of Pisa, Pisa

Unknown

Statistical Unit, Institute of Biomathematics, University of Urbino, Urbino

All Listed Sponsors
lead

IRCCS Centro San Giovanni di Dio Fatebenefratelli

OTHER

NCT01699997 - Oxytocin as Adjunctive Therapy for Schizophrenia | Biotech Hunter | Biotech Hunter